Skip to content

Clinical trials

Thyroid Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Diseases Clear all

361 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20032
20042
20055
200611
20076
20087
20097
201010
201112
20129
201317
201410
20158
201621
201726
201813
201923
202027
202125
202225
202322
202430
202523
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed176
Unknown status85
Recruiting36
Terminated20
Not yet recruiting14
Active, not recruiting13
Withdrawn9
Enrolling by invitation8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University10
Memorial Sloan Kettering Cancer Center7
Seoul National University Hospital6
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)5
Shanghai 6th People's Hospital5
Medstar Health Research Institute4
National Taiwan University Hospital4
Aristotle University Of Thessaloniki3
Eli Lilly and Company3
M.D. Anderson Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Diseases361
Thyroid Neoplasms49
Neoplasms26
Hypothyroidism25
Thyroid Nodule25
Parathyroid Diseases20
Graves Disease18
Endocrine System Diseases17
Goiter17
Hyperthyroidism15

Trials

Showing 51 to 75 of 361. Each trial links to its page on Pharma Observatory.

261 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.